Illumina, Inc. (ILMN)
USD 76.25
(2.56%)
USD 76.25
(2.56%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -7.35 USD | 73.8% |
| 2022 | -28.05 USD | -652.17% |
| 2021 | 5.08 USD | 13.9% |
| 2020 | 4.46 USD | -34.6% |
| 2019 | 6.82 USD | 21.35% |
| 2018 | 5.62 USD | 13.08% |
| 2017 | 4.97 USD | 57.78% |
| 2016 | 3.15 USD | -0.94% |
| 2015 | 3.18 USD | 21.84% |
| 2014 | 2.61 USD | 161.0% |
| 2013 | 1.00 USD | -18.7% |
| 2012 | 1.23 USD | 75.71% |
| 2011 | 0.70 USD | -30.69% |
| 2010 | 1.01 USD | 71.19% |
| 2009 | 0.59 USD | 37.21% |
| 2008 | 0.43 USD | 116.73% |
| 2007 | -2.57 USD | -671.11% |
| 2006 | 0.45 USD | 273.08% |
| 2005 | -0.26 USD | -199.54% |
| 2004 | -0.09 USD | 79.33% |
| 2003 | -0.42 USD | 35.38% |
| 2002 | -0.65 USD | -54.76% |
| 2001 | -0.42 USD | 39.13% |
| 2000 | -0.69 USD | 64.8% |
| 1999 | -1.96 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 4.43 USD | 135.44% |
| 2024 Q1 | -0.79 USD | 28.83% |
| 2024 Q2 | -12.50 USD | -1482.28% |
| 2023 Q2 | -1.48 USD | -7889.47% |
| 2023 Q1 | 0.02 USD | 102.13% |
| 2023 FY | - USD | 73.8% |
| 2023 Q4 | -1.11 USD | 76.73% |
| 2023 Q3 | -4.77 USD | -222.3% |
| 2022 FY | - USD | -652.17% |
| 2022 Q4 | -0.89 USD | 96.34% |
| 2022 Q3 | -24.31 USD | -612.9% |
| 2022 Q2 | -3.41 USD | -720.0% |
| 2022 Q1 | 0.55 USD | -22.54% |
| 2021 Q1 | 1.01 USD | -42.61% |
| 2021 Q2 | 1.27 USD | 25.74% |
| 2021 Q4 | 0.71 USD | -66.03% |
| 2021 Q3 | 2.09 USD | 64.57% |
| 2021 FY | - USD | 13.9% |
| 2020 Q3 | 1.23 USD | 284.37% |
| 2020 Q4 | 1.76 USD | 43.09% |
| 2020 FY | - USD | -34.6% |
| 2020 Q1 | 1.18 USD | -27.61% |
| 2020 Q2 | 0.32 USD | -72.88% |
| 2019 Q4 | 1.63 USD | 2.52% |
| 2019 FY | - USD | 21.35% |
| 2019 Q1 | 1.59 USD | 11.19% |
| 2019 Q2 | 2.01 USD | 26.42% |
| 2019 Q3 | 1.59 USD | -20.9% |
| 2018 FY | - USD | 13.08% |
| 2018 Q1 | 1.41 USD | 200.0% |
| 2018 Q2 | 1.42 USD | 0.71% |
| 2018 Q3 | 1.35 USD | -4.93% |
| 2018 Q4 | 1.43 USD | 5.93% |
| 2017 Q1 | 2.55 USD | 203.57% |
| 2017 FY | - USD | 57.78% |
| 2017 Q4 | 0.47 USD | -58.04% |
| 2017 Q3 | 1.12 USD | 27.27% |
| 2017 Q2 | 0.88 USD | -65.49% |
| 2016 FY | - USD | -0.94% |
| 2016 Q4 | 0.84 USD | -4.55% |
| 2016 Q1 | 0.61 USD | -15.28% |
| 2016 Q3 | 0.88 USD | 7.32% |
| 2016 Q2 | 0.82 USD | 34.43% |
| 2015 Q1 | 0.95 USD | -12.04% |
| 2015 Q4 | 0.72 USD | -11.11% |
| 2015 Q2 | 0.71 USD | -25.26% |
| 2015 Q3 | 0.81 USD | 14.08% |
| 2015 FY | - USD | 21.84% |
| 2014 Q4 | 1.08 USD | 63.64% |
| 2014 Q3 | 0.66 USD | 83.33% |
| 2014 Q2 | 0.36 USD | -23.4% |
| 2014 Q1 | 0.47 USD | -26.56% |
| 2014 FY | - USD | 161.0% |
| 2013 FY | - USD | -18.7% |
| 2013 Q4 | 0.64 USD | 156.0% |
| 2013 Q3 | 0.25 USD | -13.79% |
| 2013 Q2 | 0.29 USD | 261.11% |
| 2013 Q1 | -0.18 USD | -131.03% |
| 2012 Q4 | 0.58 USD | 141.67% |
| 2012 Q1 | 0.21 USD | 123.88% |
| 2012 Q3 | 0.24 USD | 26.32% |
| 2012 FY | - USD | 75.71% |
| 2012 Q2 | 0.19 USD | -9.52% |
| 2011 Q2 | 0.25 USD | 31.58% |
| 2011 Q1 | 0.19 USD | -24.0% |
| 2011 FY | - USD | -30.69% |
| 2011 Q4 | 0.09 USD | -44.82% |
| 2011 Q3 | 0.17 USD | -32.0% |
| 2010 FY | - USD | 71.19% |
| 2010 Q2 | 0.24 USD | 33.33% |
| 2010 Q3 | 0.28 USD | 16.67% |
| 2010 Q1 | 0.18 USD | 109.3% |
| 2010 Q4 | 0.25 USD | -10.71% |
| 2009 FY | - USD | 37.21% |
| 2009 Q1 | 0.15 USD | -31.82% |
| 2009 Q2 | 0.20 USD | 33.33% |
| 2009 Q4 | 0.09 USD | -38.57% |
| 2009 Q3 | 0.14 USD | -30.0% |
| 2008 FY | - USD | 116.73% |
| 2008 Q4 | 0.22 USD | 461.25% |
| 2008 Q3 | -0.06 USD | -143.5% |
| 2008 Q2 | 0.14 USD | 16.67% |
| 2008 Q1 | 0.12 USD | 426.09% |
| 2007 Q2 | 0.09 USD | 103.09% |
| 2007 Q1 | -2.79 USD | -1741.18% |
| 2007 FY | - USD | -671.11% |
| 2007 Q4 | -0.04 USD | -128.31% |
| 2007 Q3 | 0.13 USD | 50.99% |
| 2006 Q4 | 0.17 USD | 0.0% |
| 2006 FY | - USD | 273.08% |
| 2006 Q1 | -0.00 USD | -136.11% |
| 2006 Q2 | 0.08 USD | 6076.92% |
| 2006 Q3 | 0.17 USD | 118.79% |
| 2005 FY | - USD | -199.54% |
| 2005 Q2 | -0.23 USD | -1328.57% |
| 2005 Q3 | -0.02 USD | 92.43% |
| 2005 Q4 | 0.00 USD | 120.69% |
| 2005 Q1 | -0.02 USD | -119.37% |
| 2004 Q2 | -0.05 USD | 24.02% |
| 2004 Q4 | 0.08 USD | 408.92% |
| 2004 Q3 | -0.03 USD | 46.52% |
| 2004 Q1 | -0.07 USD | 2.5% |
| 2004 FY | - USD | 79.33% |
| 2003 Q2 | -0.14 USD | 6.67% |
| 2003 Q3 | -0.09 USD | 38.57% |
| 2003 Q4 | -0.07 USD | 21.05% |
| 2003 Q1 | -0.15 USD | -15.38% |
| 2003 FY | - USD | 35.38% |
| 2002 Q2 | -0.52 USD | -271.43% |
| 2002 Q4 | -0.13 USD | -8.33% |
| 2002 Q3 | -0.12 USD | 76.92% |
| 2002 Q1 | -0.14 USD | 0.0% |
| 2002 FY | - USD | -54.76% |
| 2001 FY | - USD | 39.13% |
| 2001 Q3 | -0.10 USD | 2.82% |
| 2001 Q2 | -0.10 USD | -18.19% |
| 2001 Q1 | -0.08 USD | -6.46% |
| 2001 Q4 | -0.14 USD | -44.93% |
| 2000 Q3 | -0.07 USD | 38.83% |
| 2000 Q4 | -0.08 USD | -7.63% |
| 2000 Q1 | -1.11 USD | 0.0% |
| 2000 FY | - USD | 64.8% |
| 2000 Q2 | -0.12 USD | 89.19% |
| 1999 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -1.27 USD | -478.74% |
| Applied DNA Sciences, Inc. | -15.21 USD | 51.677% |
| Aspira Women's Health Inc. | -1.81 USD | -306.077% |
| Biodesix, Inc. | -0.64 USD | -1048.438% |
| BioNexus Gene Lab Corp. | -0.17 USD | -4223.529% |
| bioAffinity Technologies, Inc. | -0.91 USD | -707.692% |
| bioAffinity Technologies, Inc. | -0.91 USD | -707.692% |
| Bionano Genomics, Inc. | -6.81 USD | -7.93% |
| CareDx, Inc | -3.54 USD | -107.627% |
| Check-Cap Ltd. | -3.00 USD | -145.0% |
| Castle Biosciences, Inc. | -2.14 USD | -243.458% |
| DarioHealth Corp. | -1.93 USD | -280.829% |
| Exact Sciences Corporation | -1.13 USD | -550.442% |
| Fulgent Genetics, Inc. | -5.63 USD | -30.551% |
| Guardant Health, Inc. | -4.28 USD | -71.729% |
| ICON Public Limited Company | 7.46 USD | 198.525% |
| IDEXX Laboratories, Inc. | 10.17 USD | 172.271% |
| Intelligent Bio Solutions Inc. | -6.38 USD | -15.204% |
| iSpecimen Inc. | -1.23 USD | -497.561% |
| Standard BioTools Inc. | -0.94 USD | -681.915% |
| MDxHealth SA | -1.66 USD | -342.771% |
| 23andMe Holding Co. | -1.40 USD | -425.0% |
| Medpace Holdings, Inc. | 9.20 USD | 179.891% |
| Myriad Genetics, Inc. | -1.39 USD | -428.777% |
| Mainz Biomed B.V. | -1.62 USD | -353.704% |
| ENDRA Life Sciences Inc. | -1.11 USD | -562.162% |
| NeoGenomics, Inc. | -0.70 USD | -950.0% |
| Neogen Corporation | -0.04 USD | -16796.552% |
| Inotiv, Inc. | -4.10 USD | -79.268% |
| Natera, Inc. | -3.78 USD | -94.444% |
| OpGen, Inc. | -41.47 USD | 82.276% |
| OPKO Health, Inc. | -0.25 USD | -2840.0% |
| Psychemedics Corporation | -0.72 USD | -920.833% |
| Prenetics Global Limited | -5.58 USD | -31.72% |
| Prenetics Global Limited | -5.58 USD | -31.72% |
| Precipio, Inc. | -4.51 USD | -62.971% |
| Personalis, Inc. | -2.25 USD | -226.667% |
| RadNet, Inc. | 0.05 USD | 15444.468% |
| Sera Prognostics, Inc. | -1.16 USD | -533.621% |
| Sotera Health Company | 0.18 USD | 4183.333% |
| Neuronetics, Inc. | -1.05 USD | -600.0% |
| Star Equity Holdings, Inc. | 7.42 USD | 199.057% |
| Star Equity Holdings, Inc. | 7.42 USD | 199.057% |
| Trinity Biotech plc | -3.14 USD | -134.076% |
| T2 Biosystems, Inc. | -19.19 USD | 61.699% |
| Twist Bioscience Corporation | -3.60 USD | -104.167% |
| Exagen Inc. | -1.34 USD | -448.507% |